Cargando…

Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy

INTRODUCTION: Mucopolysaccharide diseases are a group of lysosomal storage disorders caused by deficiencies of hydrolase enzymes, leading to pathological glycosaminoglycan accumulation. A number of mucopolysaccharidosis (MPS) types are characterised by severe airway disease, the aetiology of which i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pal, Abhijit Ricky, Mercer, Jean, Jones, Simon A., Bruce, Iain A., Bigger, Brian W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143186/ https://www.ncbi.nlm.nih.gov/pubmed/30226843 http://dx.doi.org/10.1371/journal.pone.0203216

Ejemplares similares

Strategies for the Induction of Immune Tolerance to Enzyme Replacement Therapy in Mucopolysaccharidosis Type I
por: Ghosh, Arunabha, et al.
Publicado: (2019)

Sleep disordered breathing in mucopolysaccharidosis I: a multivariate analysis of patient, therapeutic and metabolic correlators modifying long term clinical outcome
por: Pal, Abhijit Ricky, et al.
Publicado: (2015)

Anaesthesia and airway management in mucopolysaccharidosis
por: Walker, Robert, et al.
Publicado: (2012)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I
por: Arn, Pamela, et al.
Publicado: (2015)

Remodeling of the lower and upper airways
por: de Toledo Leme Constantino, Guilherme, et al.
Publicado: (2015)

Perioperative airway management for aortic valve replacement in an adult with mucopolysaccharidosis type II (Hunter syndrome)
por: Suzuki, Kazuchika, et al.
Publicado: (2018)

Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease
por: Montavon, Brittany, et al.
Publicado: (2022)

The Role of Proprotein Convertases in Upper Airway Remodeling
por: Lee, Sang-Nam, et al.
Publicado: (2022)

Assessment of Sleep in Children with Mucopolysaccharidosis Type III
por: Mahon, Louise Victoria, et al.
Publicado: (2014)

Awake airway endoscopy in mucopolysaccharidosis: a case report
por: Fernandes, Sofia, et al.
Publicado: (2021)

Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
por: Fan, Dong, et al.
Publicado: (2012)

An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III
por: Cross, Elaine M, et al.
Publicado: (2014)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
por: Lee, Yi-Hao, et al.
Publicado: (2023)

Airway management in mucopolysaccharidosis: a retrospective case series review
por: Tümer, Murat, et al.
Publicado: (2021)

Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease
por: Bignold, Rebecca, et al.
Publicado: (2022)

RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis
por: Wiesinger, Anna-Maria, et al.
Publicado: (2023)

Mucopolysaccharidosis Type I Diagnosed by Aortic and Mitral Valve Replacement
por: Sherwood, Dalton J., et al.
Publicado: (2021)

Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model
por: Sawamoto, Kazuki, et al.
Publicado: (2019)

Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of Mucopolysaccharidosis Type II
por: Gleitz, Hélène F. E., et al.
Publicado: (2017)

Airway Epithelial Cell Migration Dynamics: Mmp-9 Role in Cell–Extracellular Matrix Remodeling
por: Legrand, Claire, et al.
Publicado: (1999)

Moderate Hyperoxia Induces Extracellular Matrix Remodeling by Human Fetal Airway Smooth Muscle Cells
por: Vogel, Elizabeth R., et al.
Publicado: (2016)

Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling
por: Kuwabara, Yu, et al.
Publicado: (2018)

Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III
por: Ghosh, Arunabha, et al.
Publicado: (2017)

Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation
Publicado: (1988)

Extracellular matrix remodelling in COPD
por: Karakioulaki, Meropi, et al.
Publicado: (2020)

Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
por: Horgan, Claire, et al.
Publicado: (2022)

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
por: Schulze-Frenking, G., et al.
Publicado: (2010)

Mechanisms of upper airway remodeling following surgical interventions remain elusive
por: Singh, G Dave
Publicado: (2021)

Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Mumford, Rachel A., et al.
Publicado: (2015)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Hyo-Mental Angle and Distance: An Important Adjunct in Airway Assessment of Adult Mucopolysaccharidosis
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Flaxseed extract reduces tissue accumulation and enhances urinary excretion of chondroitin sulphate in the rat: a possible new path in substrate reduction therapy for mucopolysaccharidosis
por: Es-said, Sabir, et al.
Publicado: (2022)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Intrathecal enzyme replacement therapy reverses cognitive decline in mucopolysaccharidosis type I
por: Nestrasil, Igor, et al.
Publicado: (2017)

Impact of intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II
por: Seo, Joo-Hyun, et al.
Publicado: (2021)

Extracellular Matrix Remodeling in Human Disease
por: Sonbol, Hala Salim
Publicado: (2018)

Extracellular Vesicles and Matrix Remodeling Enzymes: The Emerging Roles in Extracellular Matrix Remodeling, Progression of Diseases and Tissue Repair
por: Nawaz, Muhammad, et al.
Publicado: (2018)

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis
por: Tebani, Abdellah, et al.
Publicado: (2018)

Airway and Extracellular Matrix Mechanics in COPD
por: Bidan, Cécile M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7hmnlqn7jeui6bugcmvah3ceqo